chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 104; Sore throat; Chills; Symptoms like alergies; Cold like symptoms; This is a spontaneous report from a contactable consumer via Pfizer Sponsored Program. A 16-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 15Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. The patient was fine until Sunday (Apr2021) then the patient had a fever of 104, sore throat, chills, and symptoms like allergies. The patient was treated with Tylenol and the fever broke but still having cold like symptoms. The reporter wants to know what should do now.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient feels tingling in tongue and metallic taste; she reports she had the same side effects with her first dose and it went away after 12 hour. She was assessed and cleared with EMS.
Patient under 18 years of age received Moderna vaccine.    Dose #1 on 7/25/21;  dose #2 on 8/22/21 (lot #021c21a).    Patient had no adverse event or significant side effects.
Rash broke out on both Legs, Back, and  Left shoulder after the second dose; She broke out on both legs and  left shoulder  injection site 2 weeks after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash broke out on both Legs, Back, and  Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and  left shoulder  injection site 2 weeks after the second shot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced RASH (Rash broke out on both Legs, Back, and  Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and  left shoulder  injection site 2 weeks after the second shot). The patient was treated with BETAMETHASONE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Rash broke out on both Legs, Back, and  Left shoulder after the second dose) and VACCINATION SITE RASH (She broke out on both legs and  left shoulder  injection site 2 weeks after the second shot) outcome was unknown.            The patient was taking Celebrex and  stopped the use of  Celebrex to see if that improves the rash, but the rash  was not recovered.   This case was linked to MOD-2021-296638 (Patient Link).
Healthy 4 year old well child visit. One hour after receiving vaccines developed fever 102.8 (Tympanic) and bilateral leg pain. Symptoms lasted 48 hours.
6 days after receiving the 1st dose of the Moderna vaccine I noticed a rectangular rash around my injection site. It was very itchy and resolved within 10 days of onset.   Upon second dose of the vaccine I experienced a very heavy menstrual cycle a week after vaccination. This was my first post-partum cycle. It was heavy and resulted in hemorrhaging. Since that time I have been treated with tranexamic acid to manage bleeding. I am unsure if this experience is connected to the vaccine.
Products were exposed to a high of 47.4F and a low of 31.4F with no reported adverse event; The patient received Menactra exposed to a high of 47.4 and a low of 31.4 degree Fahrenheit.; Initial information received on 01-Feb-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 60 years old female patient who was administered MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] that was exposed to a high of 47.4 F and a low of 31.4 F with no reported adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 25-Jan-2023, the patient received a dose of 0.5 mL of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE exposed to a high of 47.4 and a low of 31.4 degree Fahrenheit with no reported adverse event (with lot U7492AB, expiry date: 26 Oct 2023) (strength, formulation: unknown) via intramuscular route in unknown administration site for immunization (poor quality product administered).  On an unknown date the reporter reported a non-serious products were exposed to a high of 47.4 F and a low of 31.4 F with no reported adverse event (product storage error) (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken with MENINGOCOCCAL VACCINE (MENACTRA) was not applicable.  At time of reporting, the outcome was Unknown for the event products were exposed to a high of 47.4f and a low of 31.4f with no reported adverse event and was Unknown for the event the patient received menactra exposed to a high of 47.4 and a low of 31.4 degree fahrenheit..     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Unconsolable crying started 27JUN90 about 4AM; Waking fr sleep, screaming x 14 hrs; Temp 102F; Not feeding; Local redness;
Stomach pain; Painful L arm; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain) and PAIN IN EXTREMITY (Painful L arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and PAIN IN EXTREMITY (Painful L arm). At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain) and PAIN IN EXTREMITY (Painful L arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information mentioned.  Patient experienced stomach pain and pain in left arm.  Reporters causality of events with Rinvoq was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Pfizer given 12/21, within 24 hours window time frame temperature ranged b/t 101-104 (one thermometer read 104 but other one read 101) . Hard lump at injection site size of quarter w/ no  signs of infection, tachycardia for  more than three hours today heart rate as high as 149 bpm  but in the 120's during triage call. Slight 2/10 bilateral temple headache,  Denied chest pain  during triage call. Blood pressure during all 126/87, 124 bpm,  COVID=19 booster was administered at state funded site per spouse of patient on 12/22/21.
I am having allergic reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (I am having allergic reaction to the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (I am having allergic reaction to the vaccine). At the time of the report, ALLERGY TO VACCINE (I am having allergic reaction to the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by reporter. No Treatment medications were provided by reporter.
Patient awoke on 2/12/21 with altered mental status, confusion, respiratory distress, was taken to hospital by ambulance. Per ED notes from ED attending Pt presented with hypotension and respiratory distress. DNR status, patient given comfort measures and passed away in ED at 11:24 am on 2/12/21.
Sx: Redness / swelling to left upper arm. No induration. Tx: Antihistamine
3 days after getting the COVID-19 vaccine dose 2,  1 swollen lymph node below my chest.
Pt had rash all over face and abdomen.  No swelling or trouble breathing.  Gave Benadryl in the office and he improved.
The patient had a round circular redness about 6 inches in diameter on the arm . the redness spread almost all the way around the arm but lightened in color. small tender knot at injection site and rash is almost gone per patient today. 2/12/2020
Reaction started about 22 hours after the shot. Reaction included tenderness, swelling and redness ( 4 in. diameter ) at the injection site, chills, low grade fever, fatigue, nausea and vomiting. Symptoms, except fatigue, subsided in about 12 hours. It took about a week for the fatigue to subside
A couple of minutes after the shot the patient got dizzy and fainted. He was standing up but did NOT hit his head, his legs buckled and the person standing next to him caught him. He woke up a few seconds later and was wheelchaired to a room where he laid down for 30 minutes. He felt fine after that other than a little tired. After 30 minutes observation he was cleared to go home.
Information has been received from a health professional concerning an adult pt who in approx Feb 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). In approx Feb 2005, the pt experienced injection site reactions described as swelling, soreness, warmth, erythema and induration. Unspecified medical attention was sought. It was noted that the pt was treated with levofloxacin (Levaquin). Subsequently, the pt recovered. A lot check will be performed. No product quality complaint was involved. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Patient was admitted to undergo a laparoscopic partial transverse colectomy. Patient remains hospitalized. Per the EUA, hospitalizations are to be reported irrespective of attribution to the vaccine
product: COVID 19 Treatment; product: COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) at the age of 46 years for covid-19 immunisation. The patient's relevant medical history included: "Sarcoidosis" (unspecified if ongoing), notes: Other medical history: Sarcoidosis. The patient took concomitant medications. Past drug history included: Zpack, reaction(s): "Known allergies: Zpack", notes: Known allergies: Zpack. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "product: COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. On 17May2022, patient received anti-viral details: product: COVID 19 Treatment, Paxlovid. Other medication in 2weeks.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I had an upset stomach with gastrointestinal problems and a headache; I had an upset stomach with gastrointestinal problems and a headache; I just sick; I had a headache; I had tiredness; whole body aches; This is a spontaneous report from a contactable consumer. This 69-years-old female consumer reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EM9809), via an unspecified route of administration on 18Feb2021 in left arm at single dose for covid-19 immunization. The patient's medical history included arthritis, thyroid, sleep and Cholesterol. Historical vaccine included bnt162b2 (dose-1) for covid-19 immunisation. Concomitant medications included Sertraline 100 mg once a day; nortriptyline at 10 mg once a day for It helps her to sleep, meloxicam at 7.5 mg once a day for arthritis pain, rosuvastatin 10 mg once a day for cholesterol and levothyroxine 25 mg once a day for thyroid.  On 19Feb2021, the patient had tiredness and the whole-body aches. On 20Feb2021, she had a headache and on 23Feb2021, she had an upset stomach with gastrointestinal problems, and she was just sick. The outcome of the event tiredness and the whole-body aches was resolved on 20Feb2021, whereas the event headache was not resolved whereas other events was not resolved.  No follow-up attempts are possible; No further information is expected.
My heart started racing so fast, I could not even count to keep up with it. I called 911 and they was wanting to transport me by ambulance but it was expensive so I drove myself. I went to the ER. I had already took Aspirin 81 mg and while at ER, I was given 4 more Aspirin. I was giving an EKG and observation. I was discharged. The doctor at the ER referred me to a cardiologist. I eventually went to cardiologist and was prescribed Atorvastatin 20mg and Metoprolol 25mg. I had a stress test and blood work and the doctor stated that I did not have much damage to my heart. I do have another follow up appt with my cardiologist soon.
Fever 100.4 - 101.7 lasting for approximately 14 hours, chills, muscle ache.  Treatment- 200 mg ibuprofen, 3x
Patient returned call and stated that vaccine site  (Covid Vaccine) on her arm had "been red and swollen". Patient states swelling has decreased and pain has subsided.  Patient states "my mother told me to take a benadryl and I  used cold compresses". Offered patient appointment to come for evaluation. Patient states "I am feeling much better but will call if I need to come in or if symptoms do not improve.
Mother stated 2 days after he got immunization shot, he had fever with seizure which last less than 1 minute.
I think that the nurse who administered the vaccine injected it too high on my arm. A few days after the shot, my shoulder began to hurt and the pain progressively worsened over the next few weeks. The pain was in my right shoulder where the shot had been administered, my shoulder joint, my arm, the pain radiated up my neck. It was difficult to move my arm. Over the counter pain medications have not helped with the pain. After about a month the pain in my joint seemed to subside. The pain has since gotten worse and is in my arm, shoulder, and neck. My arm hurts when I am driving, working on the computer, reaching for things, and is interfering with everyday activities. The flu shot was administered as part of an employee vaccine clinic.
The patient received the first dose of the HPV vaccine on 03/12/2023.  She returned and was given the second dose on 04/19/2023.  This was too early and should have been administered after 05/12/2023.  The patient did not experience any adverse advents to the vaccine.
Complained of nausea, dry heaves, severe stomach pains, generalized weakness after taking second dose of Typhoid capsule.  Improved after taking maalox.  Made aware that this is one of the possible side affects:  advised not to continue taking if cannot tolerate.
after 15 min. observation period become light upon standing. walked to exit and fainted. patient revived, 911 called., they assessed and delivered treatment: OBSERVATION AND FLUIDS.  patient arranged own transport.
Child was getting ready for school on 2/6, passed out, hit head. Mom had to take to ER and had 6 sutures put in. Child received vaccines 2/5/2008.
Two days post vax, pt experienced flu-like symptoms with achiness and fever. Seven to ten days later, the pt had stomach pain and pain in his kidneys. He went to the emergency room. It was reported by the pt's sister that the pt's doctor stated he has kidney failure. The pt was not hospitalized. Information received on 3/2/00 reports the symptoms are ongoing.
(L) arm with generalized erythema; edema elbow up to shoulder. Tx: ice; ADVIL
This case was reported by a healthcare professional to a sales representative and described the occurrence of the redness and swelling at the injection site in a 4-year-old subject (unknown gender) who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline). On an unspecified date in either March 2006 or April 2006, the subject received the 5th dose of Infanrix in an unspecified thigh (lot AC14B018AA). On the same day, the patient received injections of poliomyelitis virus vaccine (IPOL, Aventis Pasteur) and measles mumps and rubella virus vaccine (M-M-R II, Merck). The injection sites for IPOL and MMR II were not provided. At an unspecified time after vaccination with Infanrix, on an unspecified date on or before 11 April 2006, the subject experienced redness and swelling at the injection site of Infanrix. The outcome of the events was not reported. The nurse considered the events to probably be related to vaccination with Infanrix.
pt recvd vax & on 2MAR95 mom brought pt back to ofc 6MAR95; edema 1/2 lt thigh told to use warm compresses x 48 hrs; came back to ofc 8MAR95 leg still warm & tender, t100, CBC, sed rate, BC ordered; put on Ceclor;
she had swollen arm black and blue; chest pain on climbing stairs; shortness of breath; diarrhea; congestion/nose feels running but nothing comes out; dry mouth; fever; chills; terrible headache; terrible nausea; tired very much; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (she had swollen arm black and blue), CHEST PAIN (chest pain on climbing stairs), DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea) and NASAL CONGESTION (congestion/nose feels running but nothing comes out) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lyme's disease.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (she had swollen arm black and blue), CHEST PAIN (chest pain on climbing stairs), DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), NASAL CONGESTION (congestion/nose feels running but nothing comes out), DRY MOUTH (dry mouth), PYREXIA (fever), CHILLS (chills), HEADACHE (terrible headache), NAUSEA (terrible nausea) and FATIGUE (tired very much). At the time of the report, CONTUSION (she had swollen arm black and blue), CHEST PAIN (chest pain on climbing stairs), DYSPNOEA (shortness of breath), NASAL CONGESTION (congestion/nose feels running but nothing comes out), DRY MOUTH (dry mouth), PYREXIA (fever), CHILLS (chills), HEADACHE (terrible headache), NAUSEA (terrible nausea) and FATIGUE (tired very much) had not resolved and DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant details were provided No treatment details were provided
Vomiting. Headache. Body aches. Chills. Stomach upset. Last for 5 days.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. It was reported that the patient received dose one of GARDASIL, injection (lot# and expiration date not provided) (dose not reported) in November 2012 and dose two of GARDASIL, injection (lot# and expiration date not provided) (dose not reported) in January 2013 and a dose three GARDASIL, injection (lot# and expiration date provided) (dose not reported) on 08-SEP-2014, all intramuscularly. No adverse effects reported. Additional information has been requested.
Fever, chills, achy, sore muscles, headache, vomiting, enlarged swollen painful lymph node, redness and tenderness at injection site.
mom states that pts rt leg was swollen all the way to the ankle; this occurred later on 23AUG94 shot given early afternoon; swelling occurred a few hrs later; fever 101.5, leg red, swollen & hot
She got her vaccine, had a sore arm that evening.  The next morning she woke up and said that the arm had a heaviness in her arm and leg pains.  The arm was sore for 3-4 days, but no leg pain after that.  Yesterday, 4/21/21 started having real bad stomach pains.  She went to the hospital today, 4/22/21 as she could not sleep and went to the ER and did a CAT scan and said that she had appendicitis and is going to surgery to have it removed today.
Patient was given PEDIARIX and Hepatitis B vaccines and no adverse event occurred to my knowledge.
Due to right arm pain, patient was given both vaccines in left arm. Large red/hot/swollen area. Left arm 34 cm x 16 cm with hives around edge. Temps of 101 and body aches. Seen by Dr. 11-14-08.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1. Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 2. Manufacturer unknown), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "I complain about Pfizer booster dose"; PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "both arms in so much pain"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "not recovered", described as "can't even pick up gallon of milk".  Additional information: My aunt complained earlier this morning about the booster, Can I complain about Pfizer booster dose since I had this dose, my both arms in so much pain, not getting better can't even pick up gallon of milk.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Was not able to sleep, low grade fever, chilling, nauseous, neck ache & headache. Was not able to sleep the evening of the vaccine. All of the other symptoms started in wee hours of morning of Feb 4th.  Very strange acting- wouldn?t talk or answer questions when asked how he was feeling.